Growth Metrics

Baxter International (BAX) Cash & Equivalents (2016 - 2025)

Baxter International (BAX) has disclosed Cash & Equivalents for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 11.45% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 11.45% year-over-year, with the annual reading at $2.0 billion for FY2025, 11.45% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $2.0 billion at Baxter International, up from $1.7 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $5.7 billion in Q3 2023, with the low at $1.4 billion in Q3 2024.
  • Average Cash & Equivalents over 5 years is $2.4 billion, with a median of $1.9 billion recorded in 2022.
  • The sharpest move saw Cash & Equivalents soared 257.03% in 2023, then plummeted 75.16% in 2024.
  • Over 5 years, Cash & Equivalents stood at $3.0 billion in 2021, then plummeted by 45.07% to $1.6 billion in 2022, then soared by 89.88% to $3.1 billion in 2023, then plummeted by 42.69% to $1.8 billion in 2024, then rose by 11.45% to $2.0 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $2.0 billion, $1.7 billion, and $1.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.